Home / Science / Pancreatic Cancer's Hidden Weakness Revealed
Pancreatic Cancer's Hidden Weakness Revealed
24 May
Summary
- Pancreatic cancer has a 13% survival rate after five years.
- A mutated KRAS protein was identified as a cancer growth driver.
- KRAS is a key driver in nearly all pancreatic cancer cases.
Pancreatic cancer, notorious for its grim prognosis and a mere 13 percent five-year survival rate, harbored a significant weakness for decades. This vulnerability was identified in the early 1980s with the discovery of a mutated protein known as KRAS.
This KRAS protein has been found to spur the aggressive growth and spread of various tumors. Specifically, in pancreatic cancer, it plays a pivotal role, driving nearly every diagnosed case and presenting a target for therapeutic intervention.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
